| Literature DB >> 26930630 |
Marie Eliasen1, Svend Kreiner2, Jeanette F Ebstrup1, Chalotte H Poulsen1,3, Cathrine J Lau1, Sine Skovbjerg1, Per K Fink4, Torben Jørgensen1,2,5.
Abstract
A high number of somatic symptoms have been associated with poor health status and increased health care use. Previous studies focused on number of symptoms without considering the specific symptoms. The aim of the study was to investigate 1) the prevalence of 19 somatic symptoms, 2) the associations between the symptoms, and 3) the associations between the somatic symptoms, self-perceived health and limitations due to physical health accounting for the co-occurrence of symptoms. Information on 19 somatic symptoms, self-perceived health and limitations due to physical health was achieved from a population-based questionnaire survey of 36,163 randomly selected adults in the Capital Region of Denmark in 2006/07. Chain graph models were used to transparently identify and describe the associations between symptoms, self-perceived health and limitations due to physical health. In total, 94.9% of the respondents were bothered by one or more of the 19 somatic symptoms. The symptoms were associated in a complex structure. Still, recognisable patterns were identified within organ systems/body parts. When accounting for symptom co-occurrence; dizziness, pain in legs, respiratory distress and tiredness were all strongly directly associated with both of the outcomes (γ>0.30). Chest pain was strongly associated with self-perceived health, and other musculoskeletal symptoms and urinary retention were strongly associated with limitations due to physical health. Other symptoms were either moderate or not statistically associated with the health status outcomes. Opposite, almost all the symptoms were strongly associated with the two outcomes when not accounting for symptom co-occurrence. In conclusion, we found that somatic symptoms were frequent and associated in a complex structure. The associations between symptoms and health status measures differed between the symptoms and depended on the co-occurrence of symptoms. This indicates an importance of considering both the specific symptoms and symptom co-occurrence in further symptom research instead of merely counting symptoms.Entities:
Mesh:
Year: 2016 PMID: 26930630 PMCID: PMC4773248 DOI: 10.1371/journal.pone.0150664
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
The prevalence of 19 experienced somatic symptoms during 14 days including the proportion of women and the median age in the three symptom categories.
The Regional Health Survey 2006/2007, the Capital Region of Denmark. N = 35,122–35,810.
| Prevalence in total population (%) | Proportion of women (%) | Median age (years) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Symptom | Bothered in total | Somewhat bothered | Considerably bothered | Not bothered | Somewhat bothered | Considerably bothered | Not bothered | Somewhat bothered | Considerably bothered |
| Tiredness | 60.7 | 48.8 | 11.9 | 44.0 | 53.7 | 62.0 | 49.7 | 43.9 | 43.8 |
| Neck or shoulder pain | 50.6 | 38.6 | 12.0 | 43.4 | 56.1 | 64.7 | 44.4 | 46.6 | 49.4 |
| Back pain | 49.7 | 37.5 | 12.2 | 47.7 | 52.0 | 59.6 | 44.0 | 47.2 | 50.3 |
| Pain in leg/hip/knee | 44.2 | 32.4 | 11.8 | 49.4 | 50.8 | 57.8 | 41.8 | 51.2 | 55.2 |
| Headache | 41.2 | 34.4 | 6.8 | 43.6 | 59.0 | 70.9 | 50.2 | 41.5 | 41.9 |
| Cold, running nose, coughing | 33.6 | 27.2 | 6.4 | 51.3 | 47.6 | 56.6 | 47.2 | 43.2 | 43.0 |
| Sleeplessness | 33.5 | 26.9 | 6.6 | 48.0 | 56.1 | 59.7 | 44.2 | 49.1 | 50.2 |
| Stomach pain/ abdominal distension | 32.5 | 27.2 | 5.3 | 46.4 | 58.5 | 68.1 | 47.0 | 43.7 | 45.5 |
| Indigestion, loose/hard stools | 27.8 | 23.0 | 4.8 | 48.7 | 54.4 | 65.1 | 46.0 | 45.7 | 47.8 |
| Skin rash, itching, eczema | 21.3 | 17.6 | 3.7 | 51.0 | 48.9 | 56.5 | 45.7 | 47.6 | 46.8 |
| Respiratory distress | 20.6 | 17.1 | 3.5 | 51.2 | 49.5 | 49.0 | 44.1 | 53.0 | 57.7 |
| Dizziness | 17.9 | 15.4 | 2.5 | 48.7 | 59.8 | 58.8 | 45.3 | 48.1 | 51.4 |
| Impaired hearing | 17.7 | 14.8 | 2.9 | 52.8 | 42.0 | 43.4 | 43.5 | 58.5 | 61.8 |
| Impaired vision | 17.0 | 14.6 | 2.4 | 50.4 | 52.9 | 57.2 | 43.8 | 54.8 | 56.0 |
| Rapid heart beat | 14.6 | 13.0 | 1.6 | 49.7 | 57.8 | 57.4 | 45.5 | 48.1 | 49.6 |
| Urinary incontinence | 12.7 | 10.5 | 2.2 | 48.6 | 68.5 | 65.9 | 44.2 | 58.4 | 59.7 |
| Nausea | 11.8 | 10.2 | 1.6 | 48.8 | 65.5 | 70.5 | 46.5 | 42.2 | 44.3 |
| Chest pain/discomfort | 11.1 | 9.8 | 1.3 | 51.3 | 47.1 | 51.8 | 45.5 | 49.8 | 51.3 |
| Urinary retention | 4.1 | 3.4 | 0.7 | 52.1 | 23.3 | 30.0 | 45.2 | 62.1 | 60.6 |
All numbers are weighted to account for sampling procedure and non-response. The symptoms are sorted after prevalence. The size of the study population differs according to missing on symptoms.
Column explanation: “Prevalence in total population (%)”: The percentage of the population bothered by the symptoms; totally and divided into somewhat and considerably bothered. “Proportion of women (%)”: the proportion of women in the three symptom categories. “Median age (years)”: The median age in the three symptom categories.
Fig 1Model of the block structure of the chain graph model used in the study.
Block A: age and sex. Block B: the 19 somatic symptoms in a interrelated system. Block C: self-perceived health or limitations due to physical health.
Associations between 19 experienced somatic symptoms, self-perceived health and limitations due to physical health.
N = 32,762–33,010.
| Self-perceived health | Limitations due to physical health | |||||||
|---|---|---|---|---|---|---|---|---|
| Model A | Model B | Model A | Model B | |||||
| Symptom | (95% CI) | (95% CI) | (95% CI) | (95% CI) | ||||
| Tiredness | 0.62 | (0.61–0.63) | 0.37 | (0.30–0.44) | 0.56 | (0.55–0.58) | 0.38 | (0.29–0.48) |
| Neck or shoulder pain | 0.50 | (0.48–0.51) | 0.22 | (0.15–0.29) | 0.52 | (0.50–0.53) | 0.36 | (0.27–0.44) |
| Back pain | 0.51 | (0.50–0.52) | 0.23 | (0.16–0.29) | 0.55 | (0.54–0.57) | 0.47 | (0.39–0.56) |
| Pain in leg/hip/knee | 0.56 | (0.54–0.57) | 0.37 | (0.30–0.44) | 0.61 | (0.60–0.63) | 0.65 | (0.56–0.74) |
| Headache | 0.36 | (0.34–0.37) | -0.02 | (-0.10–0.06) | 0.32 | (0.30–0.34) | 0.13 | (0.03–0.22) |
| Cold, running nose, coughing | 0.25 | (0.23–0.27) | 0.11 | (0.03–0.18) | 0.21 | (0.19–0.24) | 0.20 | (0.09–0.30) |
| Sleeplessness | 0.44 | (0.43–0.46) | 0.22 | (0.13–0.30) | 0.38 | (0.36–0.40) | 0.17 | (0.06–0.27) |
| Stomach pain/ abdominal distension | 0.39 | (0.38–0.41) | 0.14 | (0.05–0.22) | 0.32 | (0.30–0.34) | -0.09 | (-0.20–0.02) |
| Indigestion, loose/hard stools | 0.42 | (0.40–0.44) | 0.13 | (0.00–0.65) | 0.37 | (0.35–0.39) | 0.22 | (0.09–0.36) |
| Skin rash, itching, eczema | 0.30 | (0.27–0.31) | 0.05 | (-0.06–0.15) | 0.25 | (0.22–0.27) | 0.06 | (-0.08–0.19) |
| Respiratory distress | 0.65 | (0.63–0.66) | 0.55 | (0.41–0.68) | 0.59 | (0.57–0.61) | 0.59 | (0.44–0.27) |
| Dizziness | 0.59 | (0.58–0.61) | 0.30 | (0.13–0.47) | 0.55 | (0.53–0.57) | 0.38 | (0.16–0.61) |
| Impaired hearing | 0.31 | (0.29–0.33) | 0.17 | (0.06–0.28) | 0.29 | (0.27–0.31) | 0.15 | (0.00–0.29) |
| Impaired vision | 0.44 | (0.42–0.46) | 0.25 | (0.11–0.40) | 0.41 | (0.39–0.44) | 0.27 | (0.11–0.42) |
| Rapid heart beat | 0.57 | (0.55–0.59) | 0.14 | (-0.05–0.32) | 0.49 | (0.47–0.52) | 0.16 | (0.04–0.36) |
| Urinary incontinence | 0.40 | (0.37–0.42) | 0.25 | (0.10–0.43) | 0.40 | (0.38–0.43) | 0.21 | (0.04–0.38) |
| Nausea | 0.56 | (0.53–0.58) | 0.24 | (0.05–0.43) | 0.54 | (0.52–0.57) | 0.29 | (0.04–0.54) |
| Chest pain/discomfort | 0.60 | (0.57–0.62) | 0.36 | (0.15–0.58) | 0.52 | (0.49–0.54) | 0.09 | (-0.13–0.32) |
| Urinary retention | 0.52 | (0.48–0.55) | 0.32 | (0.00–0.65) | 0.48 | (0.45–0.52) | 0.40 | (0.07–0.72) |
γ: Partial correlation coefficients. A positive γ-value indicates that the symptom is associated with an increased chance of poor self-perceived health and having limitations due to physical health. A γ-value>0.30 can be regarded as a strong association. CI: Confidence interval. The size of the study population differs according to missing on symptoms.
a Model A: Adjusted for age and sex.
b Model B: Adjusted for co-occurrence of symptoms, sex and age according to the chain graph chain model in Fig 2.
* Statistically significant at a 0.01 level when accounting for multiple testing using the Benjamini-Hochberg procedure.
Fig 2Chain graph model showing the associations between symptoms.
All lines represent significant conditional associations. The numbers indicate the partial γ-coefficients. To reduce the complexity of the figure, only strong associations, i.e. γ>0.30, are shown, while associations with 0.10<γ<0.30 are included in the statistical model but not in the figure. The associations are adjusted for age and sex (not shown in the figure).